Dianthus Therapeutics targets severe autoimmune diseases with DNTH103. Read more on DNTH's promise amid competitive ...

The Morgan Stanley Pathway Funds’ (Funds) investment adviser Consulting Group Advisory Services ... Multi-manager risk, which is the risk that the investment styles of the Sub-advisers may not ...

The Morgan Stanley Pathway Funds’ (Funds) investment adviser Consulting Group Advisory Services ... Multi-manager risk, which is the risk that the investment styles of the Sub-advisers may not ...

Our novel scientific approach focuses on C1q, the initiating molecule of classical complement’s potent inflammatory pathway that when misdirected can lead to tissue damage and loss. By targeting C1q, ...

Open Modules are modules that are related to or complement your discipline. Each programme offers a range of Open Modules, providing opportunities for students to expand their breadth of learning ...

In a mouse study, they describe a brain pathway that starts with neurons (labeled in green, above) that sense inflammation signals, and the researchers were able to treat the loss of motivation by ...

Summary: Scientists have discovered a new protein pathway involved in neurodegeneration by studying “mini-brain” organoids made from patients with frontotemporal lobar degeneration (FTLD). They found ...

At 67, Sri Sri Ravi Shankar is going against the popular belief of what it means to age and exercise. While most spiritual gurus are concerned only with the mental and emotional aspects, he is a ...

We also uncover an autocrine loop centered on PAAF and showing how activated complement pathway can drive expression of PAAF-enriched ECM components. We extend our investigations more broadly and ...

Certain antibodies block the regular acetylcholine binding process, the researchers found, while others activate the immune system's complement pathway, leading to receptor destruction.

Certain antibodies block the regular acetylcholine binding process, the researchers found, while others activate the immune system's complement pathway, leading to receptor destruction.

President John Dramani Mahama has encouraged African countries to com­plement donor funds for research and innovation. He said it was time African countries intentionally made budgetary allocations ...